Allspring Global Investments Holdings LLC Trims Holdings in SPDR S&P Biotech ETF $XBI

Allspring Global Investments Holdings LLC decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 59.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 71,538 shares of the exchange traded fund’s stock after selling 105,474 shares during the period. Allspring Global Investments Holdings LLC owned 0.11% of SPDR S&P Biotech ETF worth $9,196,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Morgan Stanley increased its stake in SPDR S&P Biotech ETF by 8.3% in the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after acquiring an additional 1,536,122 shares during the period. Avoro Capital Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $256,053,000. Bessemer Group Inc. raised its stake in SPDR S&P Biotech ETF by 13.5% during the 4th quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after purchasing an additional 220,244 shares during the period. Finally, Ameriprise Financial Inc. raised its stake in SPDR S&P Biotech ETF by 40.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after purchasing an additional 353,351 shares during the period.

SPDR S&P Biotech ETF Trading Down 1.5%

NYSEARCA XBI opened at $152.11 on Thursday. SPDR S&P Biotech ETF has a 12 month low of $84.39 and a 12 month high of $165.71. The stock has a market cap of $10.21 billion, a PE ratio of 11.47 and a beta of 0.82. The stock’s 50 day moving average is $143.49 and its 200 day moving average is $133.10.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.